Literature DB >> 8917040

Detection of pulmonary aspiration of gastric contents in an animal model by assay of peptic activity in bronchoalveolar fluid.

M M Badellino1, R F Buckman, P J Malaspina, C A Eynon, G M O'Brien, F Kueppers.   

Abstract

OBJECTIVE: To determine whether peptic activity in bronchoalveolar fluid, due to the presence of the gastric proteolytic enzyme pepsin, could serve as a biochemical marker for pulmonary aspiration of gastric contents.
DESIGN: Prospective, experimental trial.
SETTING: A university animal research laboratory.
SUBJECTS: Thirty-six New Zealand rabbits, weighing 2 to 4 kg.
INTERVENTIONS: New Zealand rabbits were anesthetized, intubated via tracheostomy, and mechanically ventilated. Pulmonary aspiration was induced by the intratracheal instillation of 2 mL/kg human gastric juice (pH 1.2 +/- 0.2; pepsin activity 0.02 +/- 0.006 microgram/mL; human gastric juice group, n = 24) or normal saline solution (pH 5.2 +/- 0.2; normal saline solution group; n = 12). Mechanical ventilation was continued. Bronchoalveolar lavage was performed at 15 mins (human gastric juice group, n = 8; normal saline solution group, n = 4), 30 mins (human gastric juice group, n = 8; normal saline solution group, n = 4), or 60 mins (human gastric juice group, n = 8; normal saline solution group, n = 4) postaspiration.
MEASUREMENTS AND MAIN RESULTS: Peak airway pressure and PaO2 values were measured at baseline and 15 and 30 mins after aspiration. The pH of retrieved bronchoalveolar lavage fluid was measured and pepsin activity in sample fluid was determined. Changes from baseline in peak airway pressure and PaO2 were significant in human gastric juice animals at 15 and 30 mins when compared with normal saline solution animals (PaO2 -4% vs. -44%, peak airway pressure 20% vs. 36% at 15 mins; PaO2 -16% vs. -79%, peak airway pressure 28% vs. 69% at 30 mins; normal saline solution group vs. human gastric juice group, p < .02). Bronchoalveolar lavage fluid pH was not significantly different between groups at any time postaspiration (6.6 +/- 0.7 vs. 6.0 +/- 0.4 at 15 mins; 7.4 +/- 0.9 vs. 6.5 +/- 0.4 at 30 mins; 7.2 +/- 0.5 vs. 6.4 +/- 0.4 at 60 mins, normal saline solution group vs. human gastric juice group, p = NS). No peptic activity was present in bronchoalveolar lavage fluid from normal saline solution animals at any time. In the human gastric juice group, peptic activity was detected in postaspiration bronchoalveolar lavage fluid in eight of eight animals at 15 mins, six of eight animals at 30 mins, and five of eight animals at 60 mins (normal saline solution group vs. human gastric juice group; p < .001 at 15 mins, p < .01 at 30 mins, p = NS at 60 mins). Peptic activity of bronchoalveolar lavage fluid varied; mean values were greater at 15 mins than at 30 or 60 mins (pepsin activity: 0.004 +/- 0.002 microgram/mL vs. 0.002 +/- 0.001 microgram/mL vs. 0.0006 +/- 0.0001 microgram/mL, respectively, p < .05).
CONCLUSIONS: The results of this study suggest that peptic activity in bronchoalveolar lavage fluid can be detected up to 60 mins after induced, experimental gastric juice aspiration and may prove a clinically useful biochemical marker for episodes of occult pulmonary aspiration of gastric contents.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8917040     DOI: 10.1097/00003246-199611000-00019

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  9 in total

1.  Pepsin as a marker for pulmonary aspiration.

Authors:  Norma A Metheny; Yie-Hwa Chang; Jing Song Ye; Sharon J Edwards; Julie Defer; Thomas E Dahms; Barbara J Stewart; Kathleen S Stone; Ray E Clouse
Journal:  Am J Crit Care       Date:  2002-03       Impact factor: 2.228

Review 2.  Biomarkers in the diagnosis of aspiration syndromes.

Authors:  Philippe Abou Jaoude; Paul R Knight; Patricia Ohtake; Ali A El-Solh
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

3.  Pepsin A in Tracheal Secretions From Patients Receiving Mechanical Ventilation.

Authors:  Steven Talbert; Annette M Bourgault; Kimberly Paige Rathbun; Bassam Abomoelak; Chirajyoti Deb; Devendra Mehta; Mary Lou Sole
Journal:  Am J Crit Care       Date:  2021-11-01       Impact factor: 2.207

4.  Detection of pepsin in tracheal secretions after forced small-volume aspirations of gastric juice.

Authors:  Norma A Metheny; Thomas E Dahms; Yie-Hwa Chang; Barbara J Stewart; Patricia A Frank; Ray E Clouse
Journal:  JPEN J Parenter Enteral Nutr       Date:  2004 Mar-Apr       Impact factor: 4.016

5.  Intubation Setting, Aspiration, and Ventilator-Associated Conditions.

Authors:  Steven Talbert; Christine Wargo Detrick; Kimberly Emery; Aurea Middleton; Bassam Abomoelak; Chirajyoti Deb; Devendra I Mehta; Mary Lou Sole
Journal:  Am J Crit Care       Date:  2020-09-01       Impact factor: 2.228

6.  Comparison of a salivary/sputum pepsin assay with 24-hour esophageal pH monitoring for detection of gastric reflux into the proximal esophagus, oropharynx, and lung.

Authors:  Sunitha Potluri; Frank Friedenberg; Henry P Parkman; Alan Chang; Robert MacNeal; Christopher Manus; Matthew Q Bromer; Aslam Malik; Robert S Fisher; Thomas Nugent; Vinod K Thangada; Friedrich Kueppers; Larry S Miller
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

7.  Prevalence of pediatric aspiration-associated extraesophageal reflux disease.

Authors:  Elizabeth A Kelly; Daiva E Parakininkas; Steven L Werlin; James F Southern; Nikki Johnston; Joseph E Kerschner
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2013-10       Impact factor: 6.223

8.  Pepsin Triggers Neutrophil Migration Across Acid Damaged Lung Epithelium.

Authors:  Bryan P Hurley; Rebecca H Jugo; Ryan F Snow; Tina L Samuels; Lael M Yonker; Hongmei Mou; Nikki Johnston; Rachel Rosen
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

9.  Effectiveness of cricoid pressure in preventing gastric aspiration during rapid sequence intubation in the emergency department: study protocol for a randomised controlled trial.

Authors:  Christopher E Trethewy; Julie M Burrows; Don Clausen; Steven R Doherty
Journal:  Trials       Date:  2012-02-16       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.